Immediate early response of the p62 gene encoding a non-proteasomal multiubiquitin chain binding protein  by Lee, Young Han et al.
Immediate early response of the p62 gene encoding a non-proteasomal
multiubiquitin chain binding protein
Young Han Leea;b, Jesang Koa, Insil Joung1;a, Jung-Hye Kimb, Jaekyoon Shina;*
aDivision of Tumor Virology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA
bDepartment of Biochemistry, College of Medicine, Yeungnam University, Daegu, South Korea
Received 5 August 1998; received in revised form 6 October 1998
Abstract p62 is a cytoplasmic ubiquitin chain binding protein.
Upon a variety of extracellular signals, both transcript and
protein levels of p62 were rapidly increased. These signals include
phorbol 12-myristate 13-acetate (PMA) and calcium ionomycin
for peripheral blood mononuclear cells, serum or PDGF for
serum-starved NIH3T3 cells, IL-3 for the G1 arrested pre-B cell
line Ba/F3, and PMA for a human promyelocyte line U937. The
elevation of p62 transcript level is due to temporal stabilization of
mRNA and rapid activation of the p62 gene. Cycloheximide-
induced enhanced transcription suggests the immediate early
response of the p62 gene. The rapid induction of p62 indicates the
presence of a novel ubiquitination-mediated regulatory mechan-
ism during cell proliferation and differentiation.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
When an external stimulus reaches the cell surface, a num-
ber of catalytic reactions relay the signals to the nucleus for
coordinate gene activation [1,2]. Upon stimulation, cells rap-
idly activate the very ¢rst set of genes, known as ‘primary’ or
‘immediate early response’ genes, which do not require de
novo protein synthesis for their activation [3,4]. Thus far,
the best known immediate early response genes are transcrip-
tional regulators such as jun, fos, myc, and egr [3,4]. Some
immediate early genes also encode chemokines, kinases, phos-
phatases, and ubiquitin hydrolases [3,5^9]. Immediate early
induction of ubiquitin hydrolases indicates that ubiquitina-
tion-dependent proteasomal proteolysis is a target for tran-
scriptional regulation during early changes in the cellular en-
vironment.
Proteasomal recognition of ubiquitinated substrates is likely
initiated by a proteasomal multiubiquitin chain binding sub-
unit Mcb1/S5a [10,11]. Recently, a cytoplasmic 62 kDa pro-
tein (p62) has been characterized as another ubiquitin chain
binding protein (Ko and Shin, unpublished observation; and
[12]). As p62 also interacts with signaling molecules such as
p56lck and PKCj [13,14], p62 likely regulates fates of ubiqui-
tinated proteins in a signal-dependent manner. The present
study shows that p62 is an immediate early response
gene product for a variety of signals. Thus, by analogy with
other immediate early response genes, the p62-mediated
regulatory pathway for multiubiquitinated proteins may
have an essential function in cell proliferation and di¡erentia-
tion.
2. Materials and methods
2.1. Cell culture
Human peripheral blood mononuclear cells (PBMC) were isolated
from leukophoresis packs using Ficoll gradient [15]. Cells were cul-
tured in 10% fetal calf serum (FCS) supplemented DMEM for
NIH3T3, and RPMI 1640 for PBMC, Ba/F3, and U937 cells. For
Ba/F3 cells, WEHI-3B conditioned medium was also supplemented
as a source of IL-3. For cell cycle arrest, NIH3T3 and Ba/F3 cells
were incubated either in DMEM containing 0.5% FCS for 48 h
or without supplementation of WEHI-3B conditioned medium for
16 h. Cells were stimulated by adding the following reagents into
the culture media: 15% FCS for NIH3T3, 200 U/ml recombinant
human IL-3 for Ba/F3, 20 ng/ml phorbol 12-myristate 13-acetate
(PMA) and 1 WM ionomycin for PBMC, and 20 ng/ml PMA for
U937.
2.2. Northern and Western analysis
Total RNA preparation and Northern analysis were performed as
described [16]. Brie£y, total RNA (10 Wg) was electrophoresed on 1%
agarose gel containing 6% formaldehyde, transferred onto Hybond-N
nylon membrane (Amersham), and cross-linked by UV irradiation.
The ¢lter was hybridized overnight at 42‡C with [K-32P]dCTP-labeled
probes: the 750 bp long EcoRI-BamHI fragment of human p62
cDNA [13], the 0.9 kb NcoI/SalI fragment of the human c-fos gene
puri¢ed from the pc-fos-1 plasmid [17], and the 0.85-kb XbaI-BamHI
insert from the pRGAPDH-13 plasmids [18]. After washing with
2USSC and 0.1% SDS at 25‡C, the signal was visualized by auto-
radiography. For quantitative analysis of p62 mRNA stability, cells
were either untreated or treated with PMA/ionomycin for 2, 4, or 19 h
before the addition of actinomycin D (10 Wg/ml). To measure the
stability of p62 mRNA in PBMC, total RNA was isolated from the
cells at the indicated times after addition of actinomycin D (10 Wg/ml),
and the p62 transcript level was analyzed by Northern blot. Western
blot analysis was performed as described [13] using rabbit polyclonal
anti-human p62 antiserum raised against a C-terminal peptide (Ser407
to Asp423). The immunogen site is well conserved (100% identical) in
murine p62 [14]. In all experiments, immunoblots were subsequently
stripped in a bu¡er containing 62.5 mM Tris, pH 6.7, 100 mM
2-mercaptoethanol and 2% SDS for 30 min at 55‡C, and then re-
probed with rabbit anti-MAPK antibody (UBI).
2.3. Nuclear run-on assay
Nuclear run-on was performed following published procedures [19].
PBMC were treated with PMA/ionomycin for the indicated times, and
then nuclei were isolated from 5U106 cells. After in vitro transcrip-
tion in the presence of [K-32P]UTP, radiolabeled RNA transcripts
were puri¢ed and used for hybridization. pBluescript plasmids con-
taining full length cDNAs for human p62 and c-fos, or empty plasmid
were linearized, denatured, and immobilized on the Hybond-N nylon
membrane. The membrane was hybridized for 48 h at 42‡C with the
radiolabeled transcripts, washed twice in 2USSC and 0.1% SDS at
room temperature and once each in 0.2USSC and 0.5% SDS at 55‡C
for 1 h, and then autoradiographed.
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3. Results and discussion
3.1. Immediate early response of the p62 gene in PBMC
Most T cells in PBMC maintain their quiescence until prop-
er antigenic stimulation that leads to clonal expansion. Simul-
taneous treatment with PMA and ionomycin has been widely
used to mimic the antigenic stimulation [19]. Time-dependent
changes in message and protein levels of p62 were examined in
PBMC after PMA/ionomycin treatment. Upon stimulation, a
rapid increase of both p62 transcript and protein was ob-
served within 2 h, and the elevated levels were maintained
for up to 19 h (Fig. 1A,B). During this stimulation period,
the levels of 28S rRNA and MAP kinase (MAPK) protein
were relatively constant. Under the same stimulation condi-
tion, cells progress into the S phase only after 24 h post-
stimulation (data not shown). Thus, p62 gene activation and
the following p62 protein accumulation occur very early in the
entry into the cell cycle, possibly during G0 exit.
The transcriptional inhibitor actinomycin D was used to
measure half-lives of p62 mRNA in PBMC (Fig. 1C). The
half-life of p62 mRNA was about 2.5 h in resting PBMC.
Stimulation of PBMC with PMA/ionomycin for 2 h signi¢-
cantly stabilized p62 mRNA (t1=2 = 5 h). The increased
mRNA stability then gradually decreased back to the basal
stability within 19 h. However, the increased mRNA stability
alone cannot account for the dramatic elevation of p62 tran-
script level.
Nuclear run-on assay showed that transcriptional activity
of the p62 gene is induced within 30 min after PMA/ionomy-
cin treatment (Fig. 1D). Interestingly, the induced transcrip-
tional activity of the p62 gene persisted during the 6 h obser-
vation period, while that of the c-fos gene, which is also
activated within 30 min, returns to basal level within 1 h
(Fig. 1D). These results suggest that the observed elevation
of p62 transcript level is due to a combination of transient
mRNA stabilization and continuous activation of transcrip-
tion.
A possibility of immediate early response of the p62 gene
was then examined. As expected, mRNA level of c-fos in
PBMC was rapidly induced and the induction was largely
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Fig. 1. E¡ects of PMA/ionomycin on p62 expression in PBMC. A: PBMC was stimulated with PMA/ionomycin for the indicated times, and
then 10 Wg of cytoplasmic RNA was isolated and analyzed for p62 transcripts (2.1 kb) by Northern blot. Equivalent loading of samples was
con¢rmed by staining the 28S rRNA on the same ¢lter. B: 15 Wg of total lysates from the stimulated PBMC were electrophoresed, transferred,
and analyzed for p62 and MAPK proteins by immunoblot using anti-p62 and anti-MAPK polyclonal antisera. Typical immunoreactive bands
for p62 (62 kDa) and MAPK (42 kDa and 44 kDa) are presented separately. C: PBMC were stimulated with PMA/ionomycin for 0, 2, 4, or
19 h, and then transcription was inhibited by actinomycin D. Total RNA was isolated from the cells at the indicated times after actinomycin
D treatment, and analyzed for p62 transcript by Northern blot. The data are expressed as percent of the initial p62 transcript (t = 0 for actino-
mycin D treatment). D: Nuclei were isolated at the indicated times after stimulation. Nuclear run-on assay was performed as described in Sec-
tion 2 using 10 Wg each of denatured pBluescript containing cDNAs inserts for p62 and c-fos, or without insert (vector).
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enhanced by pretreatment of cells with the translational in-
hibitor cycloheximide, con¢rming the immediate early re-
sponse of the c-fos gene (Fig. 2). Similarly, induction of p62
transcription was detected as early as 0.5 h post stimulation
and reached maximum level by 1.5 h (Fig. 2). Furthermore,
p62 transcription was also enhanced by pretreatment of cells
with cycloheximide. Thus, the p62 gene does not require de
novo protein synthesis for activation and can be categorized
as an immediate early response gene.
3.2. p62 gene activation in other cell types
Changes of p62 level by mitogenic and di¡erentiation sig-
naling have been examined in NIH3T3 ¢broblast, IL-3-de-
pendent murine pro-B lymphocytes Ba/F3, and human pro-
myelocytes U937. To this end, NIH3T3 and Ba/F3 cell lines
growth arrested by serum and IL-3 starvation were stimulated
with 15% serum and 200 U/ml human IL-3 respectively [7].
For monocytic di¡erentiation of U937, cells were treated with
20 ng/ml PMA [20]. Protein levels of p62 in the stimulated
NIH3T3 and Ba/F3 cells were markedly elevated within 2 h
after stimulation (Fig. 3A,B). A similar elevation of p62 tran-
script levels in these stimulated cells was also observed (data
not shown). Thus, it seems likely that p62 is an early respond-
er to various mitogenic stimuli in divergent cell types.
U937 can be di¡erentiated to monocyte/macrophage upon
stimulation with PMA, vitamin D3, or GM-CSF [20,21]. As
growth arrest at G1 precedes monocytic di¡erentiation of
U937, if p62 function is solely coupled with cell proliferation,
p62 level in the di¡erentiating U937 cells would decline. How-
ever, when U937 cells were induced to di¡erentiate by either
PMA (Fig. 3C) or vitamin D3 (data not shown), both the p62
protein (Fig. 3C) and the transcript (Fig. 3D) levels also rap-
idly increased and were maintained for a 72 h observation
period. Thus, the enhanced function of p62 is not restricted
to cell proliferation, but is also associated with physiological
changes during cell di¡erentiation.
The genomic structure and promoter region of the p62 gene
have been characterized [22]. The 1.8 kb long 5P-£anking re-
gion of the p62 gene contains multiple binding sites for tran-
scriptional regulatory factors including SP-1, AP-1, NF-UB,
and Ets-1 family. Furthermore, a reporter gene linked to the
5P-£anking region was rapidly activated by serum and PMA
in NIH3T3 and U937 cells respectively. Thus, the elevation of
p62 levels upon signals for proliferation and di¡erentiation
observed in the present study (Figs. 1 and 3) is indeed due
to p62 gene activation. Nevertheless, sustained expression of
p62 suggests that p62 may function to ‘keep’ rather than to
‘initiate’ the newly established cellular environments.
Recently, ubiquitin hydrolases DUB-1 and DUB-2 have
been characterized as immediate early response gene products
[7,8]. DUB-1 activity is important for the sustained prolifer-
ation of IL-3, GM-CSF, or IL-5 responsive cells by removing
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Fig. 2. E¡ect of cycloheximide on p62 transcription. Cells were pre-
treated with or without 10 Wg/ml cycloheximide (CHX) for 1 h, and
then stimulated with PMA/ionomycin for the indicated times. 10 Wg
each of total RNA was analyzed for p62 transcript by Northern
blot. The same ¢lter was stripped and reanalyzed for transcripts of
c-fos or glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Fig. 3. Induction of p62 under distinct environments. Total lysates
were prepared from (A) NIH3T3 cells quiesced in 0.2% serum for
48 h and then stimulated with 15% serum for the indicated times,
(B) Ba/F3 cells growth arrested in the IL-3 depleted RPMI medium
for 16 h and then stimulated with IL-3 (200 U/ml) for the indicated
times, and (C) U937 cells treated with PMA (20 ng/ml) for the indi-
cated times. Lysates (10 Wg protein) were analyzed for p62 and
MAPK by Western blot. D: 10 Wg each of total RNA isolated from
U937 cells treated with PMA (20 ng/ml) for the indicated times was
probed on Northern blot with a speci¢c cDNA probe for p62 or
GAPDH.
Y.H. Lee et al./FEBS Letters 438 (1998) 297^300 299
ubiquitin chains from target regulatory proteins [7]. Another
immediate early gene product, Aplysia ubiquitin hydrolase, is
essential for long-term facilitation of the synapses through
enhancing the proteasomal proteolytic activity [9]. Thus, the
regulation of the fate of ubiquitinated proteins appears to be
the essential biochemical changes in responding to extracellu-
lar stimuli, and is supported by an immediate early transcrip-
tional activation mechanism.
Proteasomal recognition of substrates is initiated by a ubiq-
uitin chain binding protein Mcb1/S5a [10,11]. Interestingly,
p62 turns out to be another multiubiquitin chain binding pro-
tein (Ko and Shin, unpublished observation). Now we show
immediate early activation of the p62 gene upon signals for
cell proliferation and di¡erentiation. Thus, p62 likely carries
an essential function in cell regulation by modifying the fate
of ubiquitinated proteins.
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